These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 24535013)
1. More research is needed to investigate the effect of denervation on blood pressure. Wang Y Hypertension; 2014 Apr; 63(4):e85. PubMed ID: 24535013 [No Abstract] [Full Text] [Related]
2. Response to more research is needed to investigate the effect of denervation on blood pressure. Schlaich M; Esler M; Fink G; Osborn J; Euler D Hypertension; 2014 Apr; 63(4):e86. PubMed ID: 24757731 [No Abstract] [Full Text] [Related]
3. Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation. Schlaich MP; Esler MD; Fink GD; Osborn JW; Euler DE Hypertension; 2014 Mar; 63(3):426-32. PubMed ID: 24324047 [No Abstract] [Full Text] [Related]
13. [Resistant hypertension and reasons for excluding patients from treatment with renal denervation]. Prkačin I; Cavrić G; Počanić D; Leder N; Vidjak V Acta Med Croatica; 2014 Apr; 68(2):117-20. PubMed ID: 26012148 [TBL] [Abstract][Full Text] [Related]
14. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects. Kjeldsen SE; Os I; Mahfoud F EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159 [No Abstract] [Full Text] [Related]
15. Case of Refractory Hypertension Controlled by Repeated Renal Denervation and Celiac Plexus Block: A Case of Refractory Sympathetic Overload. Lee CJ; Kim BK; Yoon KB; Lee HY; Dominiczak AF; Touyz RM; Jennings GLR; Cho EJ; Hering D; Park S Hypertension; 2017 Jun; 69(6):978-984. PubMed ID: 28416585 [No Abstract] [Full Text] [Related]
16. Resistant hypertension: is renal denervation the current treatment of choice? Reddi AS Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737 [TBL] [Abstract][Full Text] [Related]
18. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states. McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757 [No Abstract] [Full Text] [Related]
19. [Impact of renal denervation on expression of renalase and tyrosine hydroxylase in adult rats with spontaneous hypertension]. Guo Y; Li L; Tan L; Tang X; Yang Q; Jiang W Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):829-33. PubMed ID: 22954924 [TBL] [Abstract][Full Text] [Related]
20. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings. Esler M J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]